221 related articles for article (PubMed ID: 34187145)
21. Topical Cyclosporine Pretreatment of Ocular Surface in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Chun YH; Beak JU; Kim HS; Na KS
J Ocul Pharmacol Ther; 2018 Nov; 34(9):628-632. PubMed ID: 30289329
[TBL] [Abstract][Full Text] [Related]
22. Dry eye disease and risk factors for corneal complications in chronic ocular graft-versus-host disease.
Kate A; Singh S; Das AV; Basu S
Indian J Ophthalmol; 2023 Apr; 71(4):1538-1544. PubMed ID: 37026297
[TBL] [Abstract][Full Text] [Related]
23. In Vivo Confocal Microscopy in Dry Eye Disease Associated With Chronic Graft-Versus-Host Disease.
Kheirkhah A; Qazi Y; Arnoldner MA; Suri K; Dana R
Invest Ophthalmol Vis Sci; 2016 Sep; 57(11):4686-91. PubMed ID: 27607414
[TBL] [Abstract][Full Text] [Related]
24. Dry eye after haematopoietic stem cell transplantation.
Ogawa Y; Okamoto S; Wakui M; Watanabe R; Yamada M; Yoshino M; Ono M; Yang HY; Mashima Y; Oguchi Y; Ikeda Y; Tsubota K
Br J Ophthalmol; 1999 Oct; 83(10):1125-30. PubMed ID: 10502571
[TBL] [Abstract][Full Text] [Related]
25. Meibomian Gland Dropout in Hematological Patients Before Hematopoietic Stem Cell Transplantation.
Giannaccare G; Bonifazi F; Sebastiani S; Sessa M; Pellegrini M; Arpinati M; Moscardelli F; Versura P; Campos E
Cornea; 2018 Oct; 37(10):1264-1269. PubMed ID: 29561352
[TBL] [Abstract][Full Text] [Related]
26. Ocular graft-versus-host disease.
Hessen M; Akpek EK
Curr Opin Allergy Clin Immunol; 2012 Oct; 12(5):540-7. PubMed ID: 22892710
[TBL] [Abstract][Full Text] [Related]
27. Tear Osmolarity and Ocular Surface Parameters as Diagnostic Markers of Ocular Graft-Versus-Host Disease.
Na KS; Yoo YS; Hwang KY; Mok JW; Joo CK
Am J Ophthalmol; 2015 Jul; 160(1):143-9.e1. PubMed ID: 25870935
[TBL] [Abstract][Full Text] [Related]
28. Topical tranilast for treatment of the early stage of mild dry eye associated with chronic GVHD.
Ogawa Y; Dogru M; Uchino M; Tatematsu Y; Kamoi M; Yamamoto Y; Ogawa J; Ishida R; Kaido M; Hara S; Matsumoto Y; Kawakita T; Okamoto S; Tsubota K
Bone Marrow Transplant; 2010 Mar; 45(3):565-9. PubMed ID: 19633693
[TBL] [Abstract][Full Text] [Related]
29. Assessment of dry eye in a GVHD murine model: Approximation through tear osmolarity measurement.
Martínez-Carrasco R; Sánchez-Abarca LI; Nieto-Gómez C; García EM; Ramos TL; Velasco A; Sánchez-Guijo F; Aijón J; Hernández-Galilea E
Exp Eye Res; 2017 Jan; 154():64-69. PubMed ID: 27818317
[TBL] [Abstract][Full Text] [Related]
30. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.
Demiryay E; Yaylali V; Cetin EN; Yildirim C
Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057
[TBL] [Abstract][Full Text] [Related]
31. [Ocular graft-versus-host disease: An often misdiagnosed etiology of dry eye syndrome].
Moyal L; Adam R; Akesbi J; Rodallec FT; Nordmann JP
J Fr Ophtalmol; 2017 Feb; 40(2):122-125. PubMed ID: 28109687
[TBL] [Abstract][Full Text] [Related]
32. How does ocular graft-versus-host disease fit under the dry eye umbrella? A review.
Kantor NB; Tovar A; Wang T; Galor A
Clin Exp Ophthalmol; 2024 Mar; 52(2):167-185. PubMed ID: 38204146
[TBL] [Abstract][Full Text] [Related]
33. Ocular surface system alterations in ocular graft-versus-host disease: all the pieces of the complex puzzle.
Giannaccare G; Pellegrini M; Bernabei F; Scorcia V; Campos E
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1341-1351. PubMed ID: 30944986
[TBL] [Abstract][Full Text] [Related]
34. Ocular findings after allogeneic hematopoietic stem cell transplantation.
Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
[TBL] [Abstract][Full Text] [Related]
35. Graft Versus Host Disease-Associated Dry Eye: Role of Ocular Surface Mucins and the Effect of Rebamipide, a Mucin Secretagogue.
Shamloo K; Barbarino A; Alfuraih S; Sharma A
Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4511-4519. PubMed ID: 31675422
[TBL] [Abstract][Full Text] [Related]
36. Ocular graft versus host disease in allogenic haematopoetic stem cell transplantation in a tertiary care centre in India.
Khan R; Nair S; Seth T; Mishra P; Mahapatra M; Agarwal T; Tandon R; Vanathi M
Indian J Med Res; 2015 Nov; 142(5):543-8. PubMed ID: 26658588
[TBL] [Abstract][Full Text] [Related]
37. Validation of measurement scales in ocular graft-versus-host disease.
Inamoto Y; Chai X; Kurland BF; Cutler C; Flowers ME; Palmer JM; Carpenter PA; Heffernan MJ; Jacobsohn D; Jagasia MH; Pidala J; Khera N; Vogelsang GB; Weisdorf D; Martin PJ; Pavletic SZ; Lee SJ;
Ophthalmology; 2012 Mar; 119(3):487-93. PubMed ID: 22153706
[TBL] [Abstract][Full Text] [Related]
38. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
Ogawa Y; Okamoto S; Mori T; Yamada M; Mashima Y; Watanabe R; Kuwana M; Tsubota K; Ikeda Y; Oguchi Y
Bone Marrow Transplant; 2003 Apr; 31(7):579-83. PubMed ID: 12692625
[TBL] [Abstract][Full Text] [Related]
39. Corneal fluorescein staining and ocular symptoms but not Schirmer test are useful as indicators of response to treatment in chronic ocular GVHD.
Amparo F; Shikari H; Saboo U; Dana R
Ocul Surf; 2018 Jul; 16(3):377-381. PubMed ID: 29763694
[TBL] [Abstract][Full Text] [Related]
40. [A 0,05% cyclosporine treatment of the advanced dry eye syndrome].
Kujawa A; Rózycki R
Klin Oczna; 2005; 107(4-6):280-6. PubMed ID: 16118939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
